SCHEMBL4438729

SCHEMBL4438729

COC(=O)c1ccc2c(c1)C(C(N)=O)C(=O)N2C1CCN(CC(=O)N2CCC3(CC2)CC3)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.36
ALOX15 P16050 1/20 0.36
ALDH1A1 P00352 5/20 0.36
OPRL1 P41146 1/20 0.36
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 5/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
HPGD P15428 2/20 0.35
ATM Q13315 1/20 0.35
MAPT P10636 1/20 0.35
XIAP P98170 1/20 0.33
BIRC2 Q13490 1/20 0.33
SRD5A1 P18405 1/20 0.33
SRD5A2 P31213 1/20 0.33
CYP2D6 P10635 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4555488 0.92 OPRL1 (0.37) HSD17B10ALOX15ALDH1A1OPRL1KMT2A
SCHEMBL4437940 0.81 OPRL1 (0.45) HSD17B10ALOX15ALDH1A1OPRL1KMT2A
SCHEMBL4432833 0.72 OPRL1 (0.46) HSD17B10ALOX15ALDH1A1OPRL1KMT2A
SCHEMBL4436720 0.70 PLD1 (0.43) OPRL1KMT2A
SCHEMBL5000753 0.67 OPRL1 (0.45) HSD17B10ALOX15ALDH1A1OPRL1KMT2A
SCHEMBL4444348 0.67 OPRL1 (0.47) HSD17B10ALOX15ALDH1A1OPRL1KMT2A
SCHEMBL4440650 0.64 CHRM4 (0.41) OPRL1KMT2A
Hydrochloric Acid SCHEMBL4555075 0.64 CHRM4 (0.41) OPRL1KMT2A
SCHEMBL4437932 0.63 YEATS4 (0.52) ALDH1A1
SCHEMBL4437442 0.62 PLD1 (0.38) OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121656-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE Pfizer Products Inc. (US) 2009-11-25 EP claimed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US claimed
WO-2008084300-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER PRODUCTS INC. (US) 2008-07-17 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE SPTLC1, SPTLC2, CPT1A HSD17B10 535/4885ALOX15 827/4885ALDH1A1 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.